Dr. Rajat Thawani is an Assistant Professor of Medicine within the Division of Hematology/l and Oncology at the Knight Cancer Institute at OHSU. He obtained his medical degree from the University College of Medical Sciences and subsequently completed his residency at Maimonides Medical Center. Following this, Dr. Thawani advanced his training through a fellowship in Hematology and Oncology at Oregon Health and Science University, culminating in a role as Chief Fellow in 2023. His expertise is prominently concentrated in the treatment of lung cancer, particularly in non-smokers as well as those who have experienced therapeutic failure with standard chemoimmunotherapy protocols. His research interests are directed toward the intersection of targeted therapies and immune resistance in lung cancer patients.